Gut microbiota in health and disease: advances and future prospects
MedComm · 2024-12 · 5 (12)
DOI: 10.1002/mco2.70012 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift MedComm, online erschienen am 20.11.2024. Verfasst von Yusheng Zhang und 6 weiteren Autor:innen. Beteiligte Einrichtung: Beijing Key Laboratory of Traditional Chinese Medicine Basic Research on Prevention and Treatment for Major Diseases Experimental Research Center Chi…. Die Arbeit wurde bisher 64-mal zitiert (Crossref) und nennt 302 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: China Academy of Chinese Medical Sciences, National Natural Science Foundation of China.
Abstract (Originalsprache)
The gut microbiota plays a critical role in maintaining human health, influencing a wide range of physiological processes, including immune regulation, metabolism, and neurological function. Recent studies have shown that imbalances in gut microbiota composition can contribute to the onset and progression of various diseases, such as metabolic disorders (e.g., obesity and diabetes) and neurodegenerative conditions (e.g., Alzheimer's and Parkinson's). These conditions are often accompanied by chronic inflammation and dysregulated immune responses, which are closely linked to specific forms of cell death, including pyroptosis and ferroptosis. Pathogenic bacteria in the gut can trigger these cell death pathways through toxin release, while probiotics have been found to mitigate these effects by modulating immune responses. Despite these insights, the precise mechanisms through which the gut microbiota influences these diseases remain insufficiently understood. This review consolidates recent findings on the impact of gut microbiota in these immune‐mediated and inflammation‐associated conditions. It also identifies gaps in current research and explores the potential of advanced technologies, such as organ‐on‐chip models and the microbiome–gut–organ axis, for deepening our understanding. Emerging tools, including single‐bacterium omics and spatial metabolomics, are discussed for their promise in elucidating the microbiota's role in disease development.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Beijing Key Laboratory of Traditional Chinese Medicine Basic Research on Prevention and Treatment for Major Diseases Experimental Research Center China Academy of Chinese Medical Sciences Beijing China.
- School of Traditional Chinese Medicine Southern Medical University Guangzhou China.
- School of Life Sciences Beijing University of Chinese Medicine Beijing China.
- State Key Laboratory for Quality Ensurance and Sustainable Use of Dao-di Herbs China Academy of Chinese Medical Sciences Beijing China.
ORCID-Profile: Yusheng Zhang
Förderung
- China Academy of Chinese Medical Sciences
- National Natural Science Foundation of China
Zitieren
APA
Zhang, Y., Wang, H., Sang, Y., Liu, M., Wang, Q., Yang, H., & Li, X. (2024). Gut microbiota in health and disease: advances and future prospects. MedComm, 5(12). https://doi.org/10.1002/mco2.70012
Vancouver
Zhang Y, Wang H, Sang Y, Liu M, Wang Q, Yang H, et al. Gut microbiota in health and disease: advances and future prospects. MedComm. 2024;5(12). doi:10.1002/mco2.70012
BibTeX
@article{Zhang2024,
author = {Zhang, Yusheng and Wang, Hong and Sang, Yiwei and Liu, Mei and Wang, Qing and Yang, Hongjun and Li, Xianyu},
title = {Gut microbiota in health and disease: advances and future prospects},
journal = {MedComm},
year = {2024},
volume = {5},
number = {12},
doi = {10.1002/mco2.70012}
}
EUVIMED